Despite Calls for a Moratorium, More ‘Three-Parent’ Babies Expected Soon
By Emily Mullin,
One Zero
| 09. 16. 2019
Clinics in Europe say they will continue offering a controversial IVF procedure
At least 10 babies have been born to apparently infertile women as a result of a controversial in vitro fertilization procedure that involves combining a mother’s egg with a donor one. The technique is often referred to as “three-person IVF” because the baby ends up with DNA from three people — the mother, the father, and an egg donor.
One of the births was reported in April by a Greek clinic performing the procedure, also known as mitochondrial replacement therapy, or mitochondrial donation. Now, fertility experts in Europe are calling for a moratorium on using the technique for women who have struggled to conceive.
The European Society of Human Reproduction and Embryology (ESHRE) has issued a statement urging “extreme caution” on the use of mitochondrial replacement for cases of infertility. The organization, which represents 8,000 clinicians and scientists, says there’s not enough evidence to show that it produces higher live-birth rates than conventional IVF. However, OneZero has learned that despite the group’s recommendation, the Greek clinic, as well as another center in Ukraine, will continue to offer the procedure —...
Related Articles
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...
By Judith Levine, The Intercept | 04.04.2024
WHEN THE ALABAMA Supreme Court ruled that fertilized embryos were “extrauterine children,” it did more than imperil the future of in vitro fertilization in Alabama and, potentially, the U.S. The ruling, on the claimed “wrongful death” of frozen embryos...